272 related articles for article (PubMed ID: 18673346)
1. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
Kasbia G; Al-Gahtani F; Tay J; Labonté L; Tinmouth A; Ramsay T; Gillingham A; Yang L; Halpenny M; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Transfusion; 2008 Nov; 48(11):2421-8. PubMed ID: 18673346
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation.
Kekre N; Christou G; Mallick R; Tokessy M; Tinmouth A; Tay J; Allan DS
Transfusion; 2012 Sep; 52(9):2049-54. PubMed ID: 22321053
[TBL] [Abstract][Full Text] [Related]
4. Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation.
Iqbal T; Rajagopal T; Halpenny M; Yang L; Martin L; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Exp Hematol; 2008 Apr; 36(4):506-12. PubMed ID: 18261841
[TBL] [Abstract][Full Text] [Related]
5. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
Allan DS; Dubé P; Roy J; Busque L; Roy DC
Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249
[TBL] [Abstract][Full Text] [Related]
6. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
7. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
10. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
11. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Escolar G; Eissner G; Holler E; Carreras E
Biol Blood Marrow Transplant; 2009 May; 15(5):537-46. PubMed ID: 19361745
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
14. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation.
Perseghin P; Balduzzi A; Galimberti S; Dassi M; Baldini V; Valsecchi MG; Pioltelli P; Bonanomi S; Faccini P; Rovelli A; Pogliani EM; Uderzo C
Bone Marrow Transplant; 2003 Jul; 32(2):231-6. PubMed ID: 12838290
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
17. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
18. Storage time of transfused red blood cells and impact on clinical outcomes in hematopoietic stem cell transplantation.
Kekre N; Chou A; Tokessey M; Doucette S; Tinmouth A; Tay J; Allan DS
Transfusion; 2011 Nov; 51(11):2488-94. PubMed ID: 21569047
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases.
Auner HW; Zebisch A; Ofner P; Sill H; Linkesch W; Krause R
Ann Hematol; 2005 Aug; 84(8):532-7. PubMed ID: 15809882
[TBL] [Abstract][Full Text] [Related]
20. Disturbance of pro-oxidative/antioxidative balance in allogeneic peripheral blood stem cell transplantation.
Sari I; Cetin A; Kaynar L; Saraymen R; Hacioglu SK; Ozturk A; Kocyigit I; Altuntas F; Eser B
Ann Clin Lab Sci; 2008; 38(2):120-5. PubMed ID: 18469356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
